Effect of isoflavone extracts from Glycine max on human endothelial cell damage and on nitric oxide production

Menopause

Volumn 16, Issue 3, 2009, Pages 539-544

  Paulo, Michele ^a   Salvador, Mirian Mendonça ^b   Filho, Mário Dos Anjos Neto ^b   Montes, Marlise Bonetti Agostinho ^a   Franceschini, Silvio Antônio ^a   Toloi, Maria Regina Torqueti ^a,c  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Ingá Unit of Higher Education   (Brazil)

^c Av Do Café S/N ^*  (Brazil)

Author keywords

Antioxidant; Cell damage; Endothelial cell.; Nitric oxide; Soy isoflavones

Indexed keywords

BIOCHANIN A; DAIDZEIN; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FORMONONETIN; FULVESTRANT; GENISTEIN; HYDROGEN PEROXIDE; ISOFLAVONE DERIVATIVE; LIPOPOLYSACCHARIDE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE;

ARTICLE; CELL DAMAGE; CELL PROTECTION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; REGULATORY MECHANISM; SOYBEAN; UMBILICAL VEIN;

ANTIOXIDANTS; CELL LINE; CELL SURVIVAL; ENDOTHELIAL CELLS; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; GENISTEIN; HUMANS; HYDROGEN PEROXIDE; ISOFLAVONES; NITRIC OXIDE; OXIDATIVE STRESS; SOYBEANS; UMBILICAL VEINS;

EID: 67649878867     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/gme.0b013e31818d6349     Document Type: Article

References (32)

1. Castelli WP. Cardiovascular disease in women. Am J Obstet Gynecol 1988;158:1553-1560.
2. Stampfer MJ, Colditz GA. Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prev Med 1991;20:47-63.
3. Yao S-K, Ober JC, Krishnaswami AK, et al. Endogenous nitric oxide protects against platelet aggregation and cyclic flow variations in stenosed and endothelium-injured arteries. Circulation 1992;86: 1302-1309.
4. Cohen RA. The role of nitric oxide and other endothelium-derived vasoactive substances in vascular disease. Prog Cardiovasc Dis 1995; 38:105-128.
5. Seki J, Nishio M, Kato Y, Motoyama Y, Yoshida KFK. A new nitric-oxide donor suppresses smooth muscle proliferation in the rat model of balloon angioplasty. Atherosclerosis 1995;117:97-106.
6. Rubanyi GM. The role of endothelium in cardiovascular hemostasis and diseases. J Cardiovasc Pharmacol 1993;22(suppl 4):1-14.
7. Gilligan DM, Badar DM, Panza JA, Quyyumi AA, Cannon RO. Acute vascular effects of estrogen in postmenopausal women. Circulation 1994;90:786-791.
8. Drosdzol A, Skrzypulec V, Nowosielski K, Piela B, Rozmus-Warcholi W, Walaszek A. Phytoestrogens - an alternative to hormonal replacement therapy. Wiad Lek 2004;57(suppl 1):74-77.
9. Kuiper GG, Lemmen JG, Carlsson B, et al. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor β. Endocrinology 1998;139:4252-4263.
10. Vitor RF, Mota-Filipe H, Teixeira G, et al. Flavonoids of an extract of Pterospartum tridentatum showing endothelial protection against oxi-dative injury. J Ethnopharmacol 2004;93:363-370.
11. Fernandez-Ballesteros R, Diez Nicolas J, Ruiz Torres A. Aging in Europe. Washington, DC: IOS Press, 1999.
12. Borras C, Sastre J, Garcia-Sala D, Lloret A, Pallardo FV, Vina J. Mitochondria from females exhibit higher antioxidant gene expression and lower oxidative damage than males. Free Radic Biol Med 2003; 34:546-552.
13. Borras C, Gambini J, Gomez-Cabrera MC, et al. 17β-Oestradiol up-regulates longevity-related, antioxidant enzyme expression via the ERK1 and ERK2[MAPK]/NFκB cascade. Aging Cell 2005;4:113-118.
14. Vina J, Borras C, Gambini J, Sastre J, Pallardo FV. Why females live longer than males? Importance of the upregulation of longevity-associated genes by oestrogenic compounds. FEBS Lett 2005;579: 2541-2545.
15. Takahashi S, Abe T, Gotoh J, Fukuuchi Y. Substrate-dependence of reduction of MTT: a tetrazolium dye differs in cultured astroglia and neurons. Neurochem Int 2002;40:440-448.
16. Kojima H, Nakatsubo N, Kikuchi K, et al. Detection and imaging of nitric oxide with novel fluorescent indicators: diaminofluoresceins. Anal Chem 1998;70:2446-2453.
17. Kojima H, Sakurai K, Kikuchi K, et al. Development of a fluorescent indicator for the nitric oxide based on the fluorescein chromophore. Chem Pharm Bull 1998;40:373-375.
18. Wuttke W, Jarry H, Becker T, et al. Phytoestrogens: endocrine disrupters or replacement for hormone replacement therapy? Maturitas 2003;44(suppl 1):S9-S20.
19. Beck V, Unterrieder E, Krenn L, Kubelka W, Jungbauer A. Comparison of hormonal activity (estrogen, androgen and progestin) of standardized plant extracts for large scale use in hormone replacement therapy. J Steroid Biochem Mol Biol 2003;84:259-268.
20. Simoncini T, Rabkin E, Liao JK. Molecular basis of cell membrane estrogen receptor interaction with phosphatidylinositol 3-kinase in endothelial cells. Arterioscler Thromb Vasc Biol 2003;23:198-203.
21. Vane JR, Anggard EE, Botting RM. Regulatory functions of the vascular endothelium. N Engl J Med 1990;323:27-36.
22. Angard E. Nitric oxide: mediator and medicine. Lancet 1994;343: 1199-1206.
23. Kannel WB, Hjortland MC, McNamara PM, Gordon T. Menopause and risk of cardiovascular disease: the Framingham study. Ann Intern Med 1976;85:447-452.
24. Grodstein F, Stampfer MJ, Colditz GA, et al. Postmenopausal hormone therapy and mortality. N Engl J Med 1997;336:1769-1775.
25. Sullivan JM, Vander Zwaag R, Hughes JP, et al. Estrogen replacement and coronary artery disease. Effect on survival in postmenopausal women. Arch Intern Med 1990;150:2557-2562.
26. Guetta V, Quyyumi AA, Prasad A, Panza JA, Waclawiw M, Cannon RO III. The role of nitric oxide in coronary vascular effects of estrogen in postmenopausal women. Circulation 1997;96:2795-2801.
27. The Writing Group for the Women-s Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321-333.
28. Beral V. Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 2003;362:419-427.
29. Widlansky ME, Gokce N, Keaney JF, Vita JA. The clinical implications of endothelial dysfunction. Am Coll Cardiol 2003;42:1149-1160.
30. Cooke JP. Flow NO and atherogenesis. Proc Natl Acad Sci U S A 2003;100:768-770.
31. Hermann C, Zeiher AM, Dimmeler S. Shear stress inhibits H2O2 induced apoptosis of human endothelial cells by modulation of the glutathione redox cycle and nitric oxide synthase. Arterioscler Thromb Vasc Biol 1997;17:3588-3592.
32. Cesquini M, Torsoni MA, Stopppa GR, Ogo ST. HOOH-induced oxidative damage in sickle red blood cells and the role of flavonoids. Biomed Pharmacother 2003;57:124-129.